CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-02-19 20:02 Tx date 2025-02-14	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,203,482 +365,800 vol $3.29 each	2,104,300
Filed 2025-02-19 19:43 Tx date 2025-02-14	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Common Shares 56 - Grant of rights	+90,100 vol	249,824
Filed 2025-02-05 16:34 Tx date 2025-02-04	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-72,826.789 -22,183 vol $3.28 each	159,724
Filed 2024-02-05 20:52 Tx date 2024-02-01	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,080,000 +450,000 vol $2.40 each	1,738,500
Filed 2024-02-05 20:49 Tx date 2024-02-02	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-22,183.8125 -9,593 vol $2.31 each	181,907
Filed 2024-02-05 20:44 Tx date 2024-02-01	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Common Shares 56 - Grant of rights	+112,500 vol	191,500
Filed 2023-02-06 20:06 Tx date 2023-02-01	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$916,400 +316,000 vol $2.90 each	1,288,500
Filed 2023-02-06 20:01 Tx date 2023-02-01	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Common Shares 56 - Grant of rights	+79,000 vol	79,000
Filed 2023-02-06 20:00 Tx date 2018-06-11	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-01-20 18:19 Tx date 2022-01-20	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$800,850 +285,000 vol $2.81 each	972,500
Filed 2021-02-18 07:57 Tx date 2021-02-13	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,082,500 +250,000 vol $4.33 each	687,500
Filed 2020-02-19 14:40 Tx date 2020-02-17	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	437,500
Filed 2019-03-05 Tx date 2019-03-01	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$628,375 +137,500 vol $4.57 each	337,500
Filed 2018-06-21 Tx date 2018-06-19	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,350,000 +200,000 vol $6.75 each	200,000
Filed 2018-06-21 Tx date 2018-06-11	$ABUS Arbutus Biopharma Corporation	Hastings, David Cummins 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report